文献速递妇科

机器人辅助与经阴道根治性子宫颈切除术治疗早期宫颈癌育龄患者的多中心队列研究

Robotic versus vaginal radical trachelectomy for reproductive-aged patients with early-stage cervical carcinoma: A multi-center cohort study.
PubMed 文献 · Gynecol Oncol · 2024-02-19

该回顾性多中心队列研究纳入2006至2019年间在加拿大4个转诊中心接受根治性子宫颈切除术的197例早期宫颈癌患者,比较机器人辅助(56例)与经阴道(141例)手术的肿瘤学结局。中位随访57个月,两组无复发生存率均为97%;多变量分析调整混杂因素后,手术方式与复发风险无显著关联(HR 2.1,95%CI 0.3-7.1,p=0.5),肿瘤大小超过2 cm是唯一预测复发的变量(HR 9.4,95%CI 2.8-26,p=0.003)。

要点

  • 机器人辅助与经阴道根治性子宫颈切除术两组无复发生存率均为97%。
  • 调整混杂因素后手术方式与复发风险无显著关联(HR 2.1,95%CI 0.3-7.1)。
  • 肿瘤大小超过2 cm是唯一预测复发的变量(HR 9.4,95%CI 2.8-26)。

核心结论

  • 接受机器人辅助或经阴道根治性子宫颈切除术的两组患者生存结局均极佳。
  • 调整临床重要混杂因素后,手术方式与复发风险无显著关联。

研究设计与样本

  • 回顾性多中心队列分析,纳入2006年至2019年间接受手术的患者。
  • 共纳入来自4个区域转诊中心的197例患者,56例行机器人辅助根治性子宫颈切除术,141例行经阴道根治性子宫颈切除术。
  • 研究对象为国际妇产科联盟(FIGO)2009年分期IA-IB期宫颈癌并接受根治性子宫颈切除术及淋巴结评估的女性。
  • 所有患者均通过微创技术进行淋巴结评估。

主要发现

  • 中位年龄32岁,中位肿瘤大小12 mm,中位浸润深度5 mm。
  • 中位随访57个月时,两组无复发生存率均为97%。
  • 多变量分析调整高风险病理标准、肿瘤大小和淋巴血管间隙浸润(LVSI)后,两组无进展生存期(PFS)无统计学显著差异(HR 2.1,95%CI 0.3-7.1,p=0.5)。
  • 肿瘤大小超过2 cm是唯一预测复发的变量(HR 9.4,95%CI 2.8-26,p=0.003)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A randomized non-inferiority trial showed worse survival in women with early-stage cervical cancer treated with radical hysterectomy by minimally invasive approach compared to laparotomy; the impact of surgical approach on survival following radical trachelectomy is unknown. OBJECTIVE: To examine oncologic outcomes in women with early-stage cervical cancer who underwent robotic or vaginal radical trachelectomy at Canadian cancer centers with the highest volumes of radical trachelectomy procedures. STUDY DESIGN: Retrospective multi-centre cohort analysis which includes patients who had surgery between 2006 and 2019. Women with International FIGO 2009 stage IA-IB cervical cancer who underwent radical trachelectomy and lymph node assessment were grouped by surgical approach (vaginal versus robotic surgery). RESULTS: A total of 197 patients were included from 4 regional referral centres. 56 women underwent robotic radical trachelectomy and 141 underwent vaginal radical trachelectomy. All patients had lymph node assessment by a minimally invasive technique. Median age was 32 years, median tumor size was 12 mm, and median depth of invasion was 5 mm. Recurrence-free survival was 97% in both groups at a median follow-up of 57 months. On multivariable analysis, after adjusting for previously chosen confounders (high risk pathologic criteria, tumor size, and LVSI) there was no statistically significant difference in PFS between the 2 groups (HR 2.1, 95%CI 0.3-7.1, p = 0.5). Tumor size larger than 2 cm (HR 9.4, 95%CI 2.8-26, p = 0.003) was the only variable predictive of recurrence. CONCLUSION: Survival outcomes were excellent in both cohorts of patients undergoing robotic vs. vaginal radical trachelectomy. The surgical approach was not significantly associated with risk of recurrence after adjusting for clinically important confounders.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Nica A, Benseler A, Parbhakar A, et al. Robotic versus vaginal radical trachelectomy for reproductive-aged patients with early-stage cervical carcinoma: A multi-center cohort study. Gynecol Oncol. 2024. PMID: 38377763. doi:10.1016/j.ygyno.2024.02.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。